ATXA Therapeutics

Private

DublinHealthcare & Life Scienceshttps://www.atxatherapeutics.com/

Last Round

Crowdfunding

Jan 22, 2024

Est. Valuation

$37.46M

Total Funding Raised

$10.14M

Company Overview

ATXA Therapeutics is a clinical-stage pharmaceutical company that develops novel, life-changing treatments for cardiopulmonary diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

pulmonary arterial hypertensionPAHsmall molecule drugthromboxane receptor antagonistTP antagonistclinical-stage pharmaorphan drug designationorphan drugcardiopulmonary diseasedrug discoveryPAH therapyphase I trialpharma licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ATXA Therapeutics Comps

Public and private peers based on sector, stage, and business model.

ATXA Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ATXA Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Crowdfunding	Jan 22, 2024
Grant	Oct 21, 2022
Grant	Oct 31, 2018
Seed	Apr 1, 2018

View all Funding Rounds

Key People

Founding team and executive leadership

Therese Kinsella

Chief Executive Officer

Executive Team

ATXA Therapeutics Investors

Notable investors and investment history

ATXA Therapeutics investors
Investor	Rounds
European Innovation Council	Grant
European Commission	Grant
Spark Venture Funding	Crowdfunding
Enterprise Ireland	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 5, 2026
Monthly visitors increased 51% MoM.
May 3, 2025
Monthly visitors grew 381% MoM, reaching 414.

View all signals

ATXA Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

ATXA Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ATXA Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersDublin

Employee Range5

Year Founded2015

Last FundingJan 22, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.